Valentina Gatta

Title: Valentina Gatta: Innovator in Disease Therapy

Introduction

Valentina Gatta is a prominent inventor based in Bologna, Italy. She has made significant contributions to the field of disease therapy, particularly through her innovative work on retargeted herpesviruses. Her research focuses on developing methods to target diseased cells effectively.

Latest Patents

Valentina Gatta holds a patent for a "Retargeted herpesvirus with a glycoprotein H fusion." This invention relates to a retargeted herpesvirus that includes a heterologous polypeptide fused to glycoprotein H, which specifically targets diseased cells. The patent also encompasses a nucleic acid containing the herpesvirus genome, a vector that includes this nucleic acid, and a cell that comprises either the nucleic acid or the vector. Furthermore, it details methods for utilizing the herpesvirus to kill diseased cells and for growing it in vitro. She has 1 patent to her name.

Career Highlights

Valentina Gatta is affiliated with Alma Mater Studiorum - Università di Bologna, where she conducts her research and develops her innovative therapies. Her work has garnered attention in the scientific community for its potential impact on disease treatment.

Collaborations

Valentina collaborates with Maria Gabriella Campadelli, who is also a notable figure in the field. Their partnership enhances the research and development of innovative therapeutic solutions.

Conclusion

Valentina Gatta's contributions to the field of disease therapy through her innovative patent demonstrate her commitment to advancing medical science. Her work continues to inspire future research and development in targeted therapies.